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Summary 
The Norwegian Scientific Committee for Food Safety (Vitenskapskomiteen for mattrygghet, 
VKM) has, at the request of the Norwegian Food Safety Authority (Mattilsynet; NFSA), 
assessed the intake of vitamin B6 (pyridoxine) in the Norwegian population in relation to 
tolerable upper intake levels (ULs). The existing maximum limit for vitamin B6 in food 
supplements is 4.2 mg/day. VKM has also conducted scenario calculations to illustrate the 
consequences of amending the maximum limitto 2, 6, 8, 10, 20 or 25 mg/day. 
Vitamin B6 is water soluble and comprises six compounds with vitamin B6 activity; pyridoxine 
(PN, an alcohol), pyridoxal (PL, an aldehyde) and pyridoxamine (PM, the amine) and their 
corresponding phosphates; pyridoxine 5’-phosphate (PNP), pyridoxal 5’ -phosphate (PLP) 
and pyridoaxamin 5’ –phosphate (PMP). These six forms of vitamin B6 are all present in food 
in addition to the glycosylated form, pyridoxine-5’-β-δ-glucoside (PNG), in some plants. In 
food supplements the most common vitamin B6 form is pyridoxine hydrochloride.  
Eighty to ninety percent of vitamin B6 in the body is found in muscles and estimated body 
stores in adults amount to about 170 mg with a half-life of 25-33 days. Vitamin B6 deficiency 
is mostly seen in combination with deficiency of other B vitamins. Symptoms of vitamin B6 
deficiency are anaemia and neurological abnormalities (EFSA, 2016).  
Intakes of vitamin B6 from the diet alone have not been reported to cause adverse effects. 
Sensory neuropathy has been reported to be the most sensitive adverse health effect of 
vitamin B6 supplementation. VKM proposes to adopt the tolerable upper intake level (UL) set 
by the Scientific Committee for Food (SCF) in 2000 at 25 mg/day for vitamin B6, which was 
based on a lowest observed adverse effect level (LOAEL) of 100 mg/day found in one 
randomised controlled trial. VKM recognises that there are no well-designed dose-response 
studies of long-term use available. However, for adults, no adverse effects have been 
reported at doses with vitamin B6 up to 25 mg/day.  
Dietary calculations have been performed for mean intakes and in various percentiles (P5, 
P25, P50, P75 and P95) in children (2-, 4- and 9-year-olds), adolescents (13-year-olds) and 
in adults. 
To illustrate the consequences of amending the maximum limit for vitamin B6 in food 
supplements to 2, 6, 8, 10, 20 or 25 mg/day in the different age groups, VKM has used the 
scenarios with P95 from food and added the alternative amounts of supplements. VKM has 
compared these scenarios with the tolerable upper intake levels set by the Scientific 
Committee for Food in 2000 for adults, adolescents and children. In these scenarios, the 2- 
and 4-year-old children will exceed the tolerable upper intake level with use of 6 mg/day or 
higher vitamin B6 in supplements. The 9-year-old children will exceed the tolerable upper 
intake level with supplemental use of 10 mg/day. The 13-year-old adolescents will exceed 
the tolerable upper intake level with 20 mg/day of vitamin B6 in supplements. Adults will 
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exceed the tolerable upper intake level with use of 25 mg/day of vitamin B6/pyridoxine in 
supplements. 
Key words: VKM, risk assessment, Norwegian Scientific Committee for Food Safety, vitamin B6, 
pyridoxine, food supplement, upper level, exposure. 
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Sammendrag på norsk 
Vitenskapskomiteen for mattrygghet har vurdert inntak av vitamin B6 (pyridoksin) i den 
norske befolkningen i relasjon til øvre tolerable inntaksnivåer (UL). Den eksisterende 
maksimumsgrensen for vitamin B6 i kosttilskudd er 4,2 mg/dag. VKM har også gjort 
scenarioberegninger for å illustrere konsekvensene av å endre denne maksimumsgrensen til 
2, 6, 8, 10, 20 eller 25 mg/dag.  
Vitamin B6 er vannløselig, og det finnes seks ulike forbindelser med vitamin B6-aktivitet; 
pyridoksin (PN, en alkohol), pyridoksal (PL, et aldehyd) og pyridoksamin (PM, et amin) og 
fosfater av disse: pyridoksin 5'-fosfat (PNP), pyridoksal 5 'fosfat (PLP) og pyridoaksamin 5' 
fosfat (PMP). Alle disse seks formene av vitamin B6 finnes i maten. I tillegg finnes en 
glykosylert form, pyridoksin-5'-β-δ-glukosid (PNG), i noen planter. Pyridoksin hydroklorid er 
den vanligste forbindelsen i kosttilskudd. 
80 til 90 prosent av vitamin B6 i kroppen finnes i muskler. Kroppens B6-lager er beregnet til å 
være rundt 170 mg hos voksne, med en halveringstid på 25-33 dager. Vitamin B6-mangel 
forekommer som regel i kombinasjon med mangel på andre B-vitaminer. Kliniske symptomer 
på vitamin B6-mangel er anemi og nevrologiske utslag eller sykdommer (2). 
Det er ikke rapportert om negative helseeffekter fra inntak av vitamin B6 fra mat og drikke 
alene. Sensorisk nevropati er rapportert å være det mest følsomme utfallet av kosttilskudd 
med vitamin B6. VKM foreslår å bruke det øvre tolerable inntaksnivået som er fastsatt av 
Scientific Committee for Food (SCF, 2000) på 25 mg/dag. Dette øvre tolerable inntaksnivået 
er basert på den laveste observerte dosen som har gitt negativ helseeffekt (LOAEL), i en 
randomisert kontrollert studie. VKM erkjenner at studien ikke er godt egnet som dose-
respons studie, og ikke representerer langvarig bruk. Imidlertid har det ikke blitt rapportert 
om noen negative helseeffekter hos voksne mennesker ved et inntak av vitamin B6 på opptil 
25 mg/dag. 
VKM har gjort inntaksberegninger av vitamin B6 for ulike persentiler for inntak (P5, P25, P50, 
P75 og P95), samt gjennomsnittlig inntak hos barn (2-, 4- og 9-åringer), ungdom (13-
åringer) og hos voksne menn og kvinner. 
For å illustrere konsekvensene av å endre maksimumsgrensene i kosttilskudd til 2, 6, 8, 10, 
20 eller 25 mg/dag for ulike aldersgrupper, har VKM tatt utgangspunkt P95-inntaket fra mat 
og lagt de foreslåtte mengdene fra kosttilskudd. Disse beregningene er vurdert opp mot det 
øvre tolerable inntaksnivået fastsatt av Scientific Committee for Food (2000) for voksne, 
ungdom og barn. I henhold til disse scenariene, vil vitamin B6-inntaket hos to- og fireåringer 
overskride øvre tolerabelt inntaksnivå 5 mg/dag dersom tilskudd inneholder 6 mg vitamin B6 
eller mer. Niåringer vil overskride øvre tolerabelt inntaksnivå med kosttilskudd på 10 mg 
vitamin B6 per dag. Trettenåringer vil overskride øvre tolerabelt inntaksnivå med tilskudd på 
20 mg/dag. Voksne vil overskride øvre tolerabelt inntaksnivå med kosttilskudd på 25 mg 
vitamin B6 per dag.  
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Abbreviations and/or glossary 
Abbreviations 
AI – adequate intake 
AR  – average requirement 
bw  – body weight 
DRI  – dietary reference intake 
DRV  – dietary reference value 
EAR  – estimated average requirement (IOM).  
EFSA  – European Food Safety Authority 
EVM  – Expert group on vitamins and minerals of the Food Standard Agency, UK 
GABA  – gamma-aminobutyric acid 
IOM  – Institute of Medicine, USA 
LOAEL  – lowest observed adverse effect level 
NFSA  – Norwegian Food Safety Authority [Norw.: Mattilsynet] 
NNR  – Nordic Nutrition Recommendations 
NOAEL  – no observed adverse effect level 
PL  – pyridoxal 
PLP  – pyridoxal 5’-phosphate 
PM  – pyridoxamine 
PMP  – pyridoxamine 5’-phosphate 
PN  – pyridoxine 
PNP  – pyridoxine 5’-phosphate 
PRI  – population reference intakes 
RDA  – recommended dietary allowances 
RI  – recommended intake 
SCF  – Scientific Committee for Food 
SD  – standard deviation 
SUL  – safe upper intake level 
UF  – uncertainty factor 
UL  – tolerable upper intake level 
VKM  – Norwegian Scientific Committee for Food Safety [Norw.: Vitenskapskomiteen 
for Mattrygghet] 
Glossary 
P5, P25, P50, P75 or P95-exposure is the calculated exposure at the 5, 25, 50, 75 or 95-
percentile. 
Percentile is a statistical measure indicating the value below which a given percentage of 
the observations fall. E.g. the 95-percentile is the value below which 95 percent of the 
observations are found. 
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EFSA - Dietary Reference Values (DRVs) (EFSA, 2010) 
Average Requirement (AR) is the level of intake of a defined group of individuals 
estimated to satisfy the physiological requirement of metabolic demand, as defined by a the 
specific criterion for adequacy for the nutrient, in half of the heathy individuals in a life stage 
or sex group, on the assumption that the supply of other nutrients and energy is adequate.   
If an AR cannot be determined then an Adequate Intake is used.   
Adequate Intake (AI) is defined as the average (median) daily level of intake based on 
observed, or experimentally determined approximations or estimates of a nutrient intake, by 
a group (or groups) of apparently healthy people, and therefore assumed to be adequate. 
The practical implication of an AI is similar to that of a population reference intake, i.e. to 
describe the level of intake that is considered adequate for health reasons. The 
terminological distinction relates to the different ways in which these values are derived and 
to the resultant difference in the "firmness" of the value.  
Population Reference Intake (PRI) is derived from AR of a defined group of individuals 
in an attempt to take into account the variation of requirements between individuals. PRI is 
defined as the AR + 2 x SD where SD is the standard deviation of the AR. 
 
 
Figure 1: Population reference intake (PRI and average requirements (AR), if the requirement 
has a normal distribution and the inter-individual variation is known (EFSA, 2010). 
Lower Threshold Intake (LTI) is the lowest estimate of requirement from the normal 
distribution curve, and is generally calculated on the basis of the AR minus twice its standard 
deviation (SD). This will meet the requirement of only 2.5% of the individuals in the 
population.  
Tolerable Upper intake Level (UL) is the maximum level of total chronic daily intake of a 
nutrient (from all sources) judged to be unlikely to pose a risk of adverse health effects to 
humans.  
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Figure 2: Relationship between individual intake and risk of adverse effects due to insufficient or 
excessive intake using EFSA terminology. 
IOM - Dietary Reference Intakes (DRIs)(IOM, 2000) 
Estimated Average Requirement (EAR) is a nutrient intake value that is estimated to 
meet the requirement of half the healthy individuals in a life stage and gender group.  
Recommended Dietary Allowances (RDA) is the dietary intake level that is sufficient to meet the 
nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a particular life stage and 
gender group. RDA = EAR + 2 SDEAR  or if insufficient data to calculate SD a factor of 1.2 is used to 
calculate RDA; RDA = 1.2*EAR 
Adequate Intake (AI) is the recommended intake value based on observed or experimentally 
determined approximations or estimates of nutrient intake by a group (or groups) of healthy people 
that are assumed to be adequate – used when an RDA cannot be determined 
Tolerable Upper Intake Level (UL) is the highest level of nutrient intake that is likely to pose no risk of 
adverse health effects for almost all individuals in the general population.  
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Figure 3: Dietary reference intakes using IOM terminology. 
NNR -Recommended Intake (NNR Project Group, 2012) 
Average Requirement (AR) is defined as the lowest long-term intake level of a nutrient 
that will maintain a defined level of nutritional status in an individual i.e. the level of a 
nutrient that is sufficient to cover the requirement for half of a defined group of individuals 
provided that there is a normal distribution of the requirement.  
ARNNR = EARIOM = AREFSA 
Recommended Intake (RI) is defined as the amount of a nutrient that meets the known 
requirement and maintains good nutritional status among practically all healthy individuals in 
a particular life stage or gender group. RI= AR + 2SDAR.  
RINNR = RDAIOM = PRIEFSA 
Upper Intake Level (UL) is defined as the maximum level of long-term (months or years) 
daily nutrient intake that is unlikely to pose a risk of adverse health effects in humans.  
ULNNR =ULIOM = ULEFSA 
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Figure 4: Derivation of Upper Intake Level (UL).  
UF: Uncertainty factor 
Expert group on vitamins and minerals (EVM), UK (EVM, 2003) 
Safe Upper Intake Level (SUL): EVM used SUL instead of UL and defined SUL as the 
determination of doses of vitamins and minerals that potentially susceptible individuals could 
take daily on a life-long basis, without medical supervision in reasonable safety. The setting 
of these levels provided a framework within which the consumer could make an informed 
decision about intake, having confidence that harm should not ensue. The levels so set will 
therefore tend to be conservative. 
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Background as provided by the 
Norwegian Food Safety Authority 
Directive 2002/46/EC on food supplements was implemented in Norwegian law in 2004 in 
Regulation 20 May 2004 No. 755 on food supplements. Pursuant to Directive 2002/46/EC, 
common maximum and minimum levels of vitamins and minerals in food supplements shall 
be set in the EU. 
National maximum limits for vitamins and minerals were established in the former vitamin 
and mineral supplements regulation from 1986 and were continued in the 2004 regulation.  
The European Commission started establishing common limits in 2006, but the work was 
temporarily put on standstill in 2009. The time frame for the further work is not known.  
Maximum limits for levels of vitamins and minerals in food supplements shall be set on the 
basis of the following criteria, pursuant to article 5 in Directive 2002/46/EC:  
 Upper safe levels of vitamins and minerals established by scientific risk assessment 
based on generally accepted scientific data, taking into account, as appropriate, the 
varying degrees of sensitivity of different consumer groups  
 Intake of vitamins and minerals from other dietary sources 
When the maximum levels are set, due account should also be taken of reference intakes of 
vitamins and minerals for the population. 
Pending establishment of common maximums limits in the EU, the Norwegian Food Safety 
Authority is evaluating the national maximum limits for vitamins and minerals in food 
supplements. 
Assessment of vitamin B6 
The Norwegian Food Safety Authority will evaluate the national maximum limits for B6 in the 
food supplement regulation. The minimum and maximum limits for the content of vitamins 
and minerals in food supplements are listed in Annex 1 to the food supplement regulation:  
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Background Table: Minimum and maximum limits for vitamin B6 in the food supplement 
regulation (May 2016). 
 Minimum amount per 
recommended daily dose 
Maximum amount per 
recommended daily dose 
Vitamin B6 (mg) 0.5 4.2 
Permitted vitamin B6 substances which may be used in the manufacture of food supplements 
are listed in “Forskrift om kosttilskudd 2012”,  http://www.lovdata.no/cgi-
wift/ldles?doc=/sf/sf/sf-20040520-0755.html. 
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Terms of reference as provided by the 
Norwegian Food Safety Authority 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) requests the Norwegian Scientific 
Committee for Food Safety (VKM) to assess the intake of vitamin B6 from the diet, including 
fortified products, in all age groups in the population above 1 year (mean intakes, median, 
P5, P95).  
VKM is also requested to conduct scenario estimations to illustrate the consequences of 
amending maximum limits for vitamin B6 to 2, 6, 8, 10, 20 or 25 mg/day in food 
supplements, and to evaluate these scenarios against already established tolerable upper 
intake levels. 
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Assessment vitamin B6  
1 Introduction 
Vitamin B6 is water soluble and comprises six compounds with vitamin B6 activity; pyridoxine 
(PN, an alcohol), pyridoxal (PL, an aldehyde) and pyridoxamine (PM, the amine) and their 
corresponding phosphates; pyridoxine 5’-phosphate (PNP), pyridoxal 5’ -phosphate (PLP) 
and pyridoaxamin 5’ –phosphate (PMP). These six forms of vitamin B6 are all present in food 
in addition to the glycosylated form, pyridoxine-5’-β-δ-glucoside (PNG), in some plants. In 
food supplements the most common vitamin B6 form is pyridoxine hydrochloride.  
Absorption of the non-phosphorylated forms of vitamin B6 takes place in the jejunum, mostly 
through passive diffusion, and it is calculated that about 95% of dietary B6 is absorbed 
(EFSA, 2016). Pyridoxine hydrochloride in food supplements is absorbed to a similar extent 
(IOM, 1998). PNG may be hydrolysed in the gut lumen but can also be absorbed intact. The 
bioavailability of PNG is evaluated to be 50-60% of PN and the bioavailability of vitamin B6 
from a mixed diet is therefore estimated to 75% (EFSA, 2016; Gregory et al., 1991; Tarr et 
al., 1981). PN and PM are first oxidised to PL, and then rapidly phosphorylated to PLP, 
mainly in the liver. PLP is the main circulating form of vitamin B6 (70-90%) and is considered 
the most relevant direct measure of vitamin B6 status (Lui et al., 1985). An adequate tissue 
store and enzyme functionality of PLP have been suggested to be reached at a plasma 
concentration of 20-30 nmol/L, with below 10 nmol/L indicating vitamin B6 deficiency (IOM, 
1998; NNR Project Group, 2012). A new metabolomics analysis indicated perturbation of the 
metabolism of several amino acids with a plasma level < 30 nmol/L and as a consequence 
EFSA has used this level as an indication of vitamin B6 deficiency (EFSA, 2016; Gregory et al., 
2013). Eighty to ninety percent of vitamin B6 in the body is found in muscles and estimated 
body stores amount to about 170 mg with a half-life of 25-33 days. Vitamin B6 deficiency is 
mostly seen in combination with deficiency of other B vitamins. The most typical clinical 
symptoms of vitamin B6 deficiency are anaemia and neurological abnormalities (EFSA, 2016).  
The metabolically active coenzyme forms of vitamin B6 are PLP and PMP. They function as 
coenzymes for a number of enzymes, mainly in the amino acid metabolism involving 
transamination, deamination, decarboxylation and desulfurisation, while others are related to 
one-carbon metabolism, lipid metabolism and the phosphorolytic cleavage of glycogen (in 
liver and muscle) to glucose 1-phosphate. Vitamin B6 is also involved in the biosynthesis of 
the heme component of haemoglobin and of neurotransmitters, including serotonin, 
dopamine, norepinephrine and gamma-aminobutyric acid (GABA). Excess pyridoxine is 
metabolised to the inactive form 4-pyridoxic acid which is excreted in the urine. 
Important sources of vitamin B6 are meat, milk and other dairy products, beans, nuts, fish, 
potatoes, fruits and vegetables. In the Norwegian Food Composition Table vitamin B6 is 
expressed as pyridoxine in the form of pyridoxine hydrochloride. To convert to pure 
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pyridoxine a factor of 0.823 is applied. In animal products vitamin B6 is mostly found as PLP, 
whereas in plant products vitamin B6 is most commonly in the form of PN, PNP and as PNG.   
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2 Recommendations and tolerable 
upper intake levels for vitamin B6 
2.1 Recommendations 
Different methods have been used to establish dietary reference values for vitamin B6; like 
urinary excretion of 4-pyridoxic acid, excretion of xanthurenic acid, and measurements of 
homocysteine concentration. Xanthurenic acid is a tryptophan metabolite, which normally is 
very low and requires PLP dependent enzymes, and homocysteine is dependent on vitamin 
B6 and folate to be converted to methionine. Protein intake has also been used as a 
reference to requirements because B6 is closely related to the amino acid metabolism (EFSA, 
2016). No available method gives an exact picture of vitamin B6 status, but plasma PLP 
concentration has been shown to correlate positively with both vitamin B6 intake and PLP 
store in tissue and is accepted as a standard measurement of vitamin B6 status (EFSA, 
2016).   
IOM (1998) used RCTs and review articles including tryptophan metabolites, homocysteine 
concentration and protein intake to derive at an EAR of vitamin B6 for men. IOM sat an EAR 
at 1.1 mg/day and a RDA at 1.3 mg/day for men 19-50 years. For women IOM used five 
depletion/repletion studies and one effect study with different protein intake levels. A value 
of 20 nmol/L of PLP was used as the major indicator of adequacy and EAR and RDA were 
derived at the same magnitude as for men. For men and women 51-70 years a higher dose 
of vitamin B6 is required to maintain plasma PLP concentration above 20 nmol/L. EAR for 
men 51-70 years was set at 1.4 mg/day and at 1.3 mg/day for women in the same age 
range. RDA was set to 1.7 mg/day and 1.5 mg/day for men and women 51-70 years 
respectively. The EAR and RDA for children and adolescents were extrapolated from adult 
values with standard methods. EARchild = EARadult *(weightchild/weightadult)0.75 *(1 + growth 
factor).  
The Nordic Nutritional Recommendations of 2012 (NNR) maintain the same 
recommendations as derived in 2004 (NNR Project Group, 2012). These recommendations 
are based on protein intake and an AR at 0.013 mg vitamin B6/g protein was set for both 
men and women. The value is based on results from 7 depletion-repletion studies that 
reached a plasma PLP concentration above 20 nmol/L. RI was set at 0.015 mg vitamin B6/g 
protein. The basic requirements are increased during pregnancy and lactation.  
The Norwegian recommended intakes for vitamin B6 for the different age groups are given in 
Table 2.1-1. The Norwegian recommendations are adopted from the Nordic Nutrition 
Recommendations (2012).  
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Table 2.1-1 Recommended intakes for vitamin B6 in Norway, both sexes. 
Age, both sexes Vitamin B6, mg/day 
 Men Women 
1-2 years 0.4 0.4 
2-5 years 0.7 0.7 
6-9 years 1.0 1.0 
10-13 years 1.2 1.1 
14-17 years 1.6 1.3 
18-30 years 1.5 1.2 
31-60 years 1.5 1.2 
61-74 years 1.5 1.3 
≥ 75 years 1.5 1.3 
Pregnant - 1.4 
Lactating - 1.5 
In an extensive opinion summarising current knowledge about vitamin B6 requirements, EFSA 
published dietary reference values for vitamin B6 in April 2016 (EFSA, 2016). The EFSA panel 
referred to plasma PLP > 30 nmol/L as indication of adequate vitamin B6 status (Gregory et 
al., 2013). Furthermore, it is stated that the relationship between protein intake in the range 
observed in Europe is of no relevance for vitamin B6 requirement. Based on the same studies 
as IOM in 1998 but with one additional study from 2001, EFSA derived an AR of 1.2 mg /day 
for women 20-30 years and 1.3 mg/day for women > 60 years. It was concluded that AR 
could be set to 1.3 mg/day for all women and PRI to 1.6 mg/day. The vitamin B6 AR for men 
was extrapolated from the AR for women with use of allometric scaling (ARmen = ARwomen * 
(weightmen/weightwomen)0.75 ) arriving at an AR of 1.5 mg/day and PRI of 1.7 mg/day. The 
same allometric scaling as for adults was applied to derive an AR for children and 
adolescents, including a factor for growth similar to IOM. The PRI was derived by use of a 
coefficient of variance (CV) of 10% in the absence of information on variability. In pregnancy 
an additional 0.2 mg/day is required based on a general gestational weight gain, and during 
lactation 0.1 mg/day for loss through breastfeeding.  
2.2 Tolerable upper intake levels 
Both deficient and excessive intakes of vitamin B6 can lead to neurological disturbances in 
humans. Neuropathy of the extremities was first described in women with a daily intake of 2 
to 6 g of pyridoxine in attempts to alleviate premenstrual symptoms (Schaumburg et al., 
1983). The pyridoxine neuropathy was shown to regress slowly and incompletely (Albin and 
Albers, 1990; Santoro et al., 1991). Other adverse effects reported have been dermatological 
lesions, photosensitivity and impaired memorisation, however, evidence for causal 
association with these endpoints are lacking. Sensory neuropathy with pain and numbness of 
the extremities has therefore been selected as the critical endpoint.  
An inverse relationship between duration of intake and dose is recognised and high doses 
can be tolerated for short periods without adverse effects, giving studies of short duration 
  
VKM Report 2017: 3  21 
limited value for the purpose of risk assessment. No adverse effects have been associated 
with high intakes of vitamin B6 from food sources.  
Institute of Medicine (IOM, 1998), USA 
IOM used long-term studies and case reports with administration of less than 1 g/day of 
pyridoxine hydrochloride to evaluate a UL for adults, because neurotoxicity due to higher 
intakes was known. No long-term human dose-response study was found and studies with 
single doses were used. A NOAEL of 200 mg/day of vitamin B6 was derived from two clinical 
studies; in one study 70 patients with diabetic neuropathy and carpal tunnel syndrome were 
treated with 100 – 150 mg/day of PN for up to 5 years (Bernstein and Lobitz, 1988 cited in 
IOM), and in a second study 24 patients with carpal tunnel syndrome were treated with 100 
to 300 mg pyridoxine (mean 200 mg/day) for 4 months (Del Tredici, 1985 cited in IOM). An 
uncertainty factor (UF) of 2 was used and UL was set at 100 mg/day for adults. ULs for 
children were derived based on body weight using allometric scaling: ULchild= ULadult 
*(weightchild/weightadult)0.75.   
Table 2.2-1 Tolerable upper intake levels (UL) for vitamin B6 for different age groups proposed by 
the Institute of Medicine (1998). 
Age (years) UL mg/day  
1-3 30 
4-8 40 
9-13 60 
14-18 80 
Adults  100 
Scientific Committee for Food (SCF, 2000), EU 
Based on the same human studies as IOM, SCF however, did not set a NOAEL for vitamin B6 
but rather concluded that an intake of 100 mg/day could not be excluded as a possible effect 
level for sensory neuropathy development. SCF based this conclusion on a study performed 
by Dalton and Dalton (1987) which had been disregarded by the IOM due to too many 
weaknesses (Dalton and Dalton, 1987). This study referred to 172 women attending a 
private practice specialising in premenstrual syndrome. In a cross-sectional sample of 172 
women who attended a private clinic for premenstrual syndrome, all women had serum PLP 
levels above 100 nmol/L, and mean PN intakes were 117 mg/day. Sixty percent of the 
women reported neurological symptoms. PN intake did not differ between those with 
symptoms and those without symptoms, but those with symptoms had been using vitamin B6 
supplements for a longer period of time (mean 2.9 vs. 1.6 years). Based on the study of 
Dalton and Dalton (1987) and case reports, SCF suggested 100 mg/day as a LOAEL. A 
composite UF comprising a factor of 2 to allow for long-term intake and another factor 2 for 
deficiencies in the database was applied, arriving at a UL of 25 mg/day for vitamin B6 for 
adults. It was also remarked that at an intake of 25 mg/day of vitamin B6, no adverse effects 
had been reported in a large number of published studies, also after long term use. No 
reports of adverse effects in infants born to mothers with high intakes of pyridoxine or to 
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breastfed infants had been reported, and 25 mg/day was considered to apply also to 
pregnant and lactating women. UL for children were based on ULs for adults adjusted to 
body weights. In 2012, NNR adopted the UL set by SCF.  
Table 2.2-2 Tolerable upper intake levels UL for vitamin B6 for different age groups proposed by 
the SCF (2000).  
Age (years) UL mg/day  
1-3 5 
4-6 7 
7-10 10 
11-14 20 
Adults  25 
Expert Group on Vitamins and Minerals, (EVM, 2003), UK 
In 2003, EVM proposed a safe upper level (SUL) for vitamin B6 at 10 mg/day. EVM 
disregarded all available human studies as insufficient and of poor scientific value and as 
inadequate for risk assessment. Instead EVM derived at a SUL based on one animal study by 
Phillips et al. 1978 (Phillips et al., 1978). In this subacute oral toxicity study, female beagles 
(dogs) received 0, 50 or 200 mg/pyridoxine hydrochloride/kg bw per day for 100-112 days 
(five dogs in each treatment group). No sign of toxicity was seen in the 50 mg/kg bw per 
day group, but loss of myelin was seen in the dorsal nerve roots. Dogs in the 200 mg/kg bw 
per day group showed signs of ataxia and loss of balance after 45 days. 
LOAEL was set at 50 mg/kg bw per day and SUL was derived by dividing with a UF of 300 (3 
for uncertainty between LOAEL and NOAEL, 10 for inter-species variation and 10 for inter-
individual variation) = 50/300 =0.17 mg/kg bw/day (equivalent to 10 mg/day for a 60 kg 
adult). 
 Summary and discussion tolerable upper intake level 
Table 2.2.1-1 summarises available upper intake levels for vitamin B6. 
Table 2.2.1-1: Upper intake levels for vitamin B6 from IOM, SCF, EVM and NNR. 
Intakes of vitamin B6 from food sources have not been reported to cause adverse effects.  
The hazard identification revealed sensory neuropathy as the most sensitive adverse health 
 UL/SUL 
mg/day 
Based on NOAEL 
mg/day 
LOAEL  UF 
IOM, 1998 100 2 human studies 200 - 2 
SCF, 2000 25 1 human study  100 4 
EVM, 2003 10 1 animal study  50 mg/kg bw 300 
NNR, 2012 25 Acceptance of 
SCF´s UL 
 100 4 
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effect of vitamin B6 supplementation. IOM used two RCTs in adult patients treated with 
pyridoxine for premenstrual symptoms and carpal tunnel syndrome to set a NOAEL. SCF 
referred to the same studies as IOM but included in addition one long-term study to set a 
LOAEL. EVM used a dose-response study in dogs from 1978 to set a LOAEL. In general it is 
stated that human data are preferable to animal studies to set ULs and animal studies should 
only be used when data from human studies are insufficient (EFSA, 2010). For vitamin B6 no 
dose-response study in humans was identified, but several single-dose clinical studies and 
case reports were identified.  
VKM proposes to adopt the UL set by SCF at 25 mg/day for adults for vitamin B6, which was 
based on a LOAEL found in one RCT (Dalton and Dalton, 1987). VKM recognises that there 
are no well-designed dose-response studies in humans, still uncertainties of long-term use, 
and a notion that no adverse effects have been reported with use at this intake level. 
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3 Intakes and scenarios vitamin B6 
3.1 Short description of the Norwegian dietary surveys 
The estimated intakes of vitamin B6 presented in this opinion are based on data from the 
national food consumption surveys for young children (2-year-olds), children and adolescents 
(4-, 9- and 13-year-olds) and adults (aged 18 to 70 years). The national food consumption 
surveys were conducted by the Department of Nutrition, University of Oslo in collaboration 
with the Directorate of Health, the Norwegian Food Safety Authority and the Norwegian 
Institute of Public Health. Different methodologies were used in the tree different surveys 
and thus direct comparisons between the age groups may be misleading.  
A description of the food consumption surveys and the different methodologies used is given 
below.  
Adults: "Norkost 3" is based on two 24-hour recalls by telephone at least one month apart. 
Food amounts were presented in household measures or estimated from photographs 
(Totland et al., 2012). The study was conducted in 2010/2011, and 1787 adults (925 women 
and 862 men) aged 18-70 participated. 
9- and 13-year-old children/adolescents: "Ungkost 3" is based on a 4-day food intake 
registration with a web-based food diary. All food items in the diary were linked to 
photographs for portion estimation (Hansen et al., 2016). The study was conducted in 2015 
and 636 9-year-old children and 687 13-year-old adolescents participated. 
4-year-old children: "Ungkost 3" is based on a 4-day food intake registration with a 
webbased food diary. All food items in the diary were linked to photographs for portion 
estimation (Hansen et al., 2017). The study was conducted in 2016, and 399 4-year-olds 
participated.  
2-year-old children: "Småbarnskost 2007" is based on a semi-quantitative food frequency 
questionnaire. In addition to predefined household units, food amounts were also estimated 
from photographs. The study was conducted in 2007, and a total of 1674 2-year-olds 
participated (Kristiansen et al., 2009). 
3.2 Dietary intakes of vitamin B6 in the Norwegian population 
Intakes of vitamin B6 in the various age groups and in groups of users of vitamin B6 
supplements are presented in tables in Appendix 1. The tables in Appendix 1 also include 
calculations for P25 and P75. 
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Adults (n=1787) 
The mean intake of vitamin B6 from the diet alone is 1.7 mg/day (median 1.6 mg/day) in 
adults (n=1787). Intake of B6 in P5 is 0.8 mg/day and in P95 is 3.0 mg/day. 
In Norkost 3, 416 participants (23%) reported use of supplements containing vitamin B6. 
Their mean total intake of vitamin B6 including that from food supplements is 3.6 mg/day 
(median 2.9 mg/day), P5 intake is 1.7 mg/day and P95 intake is 7.4 mg/day. 
Mean intake of vitamin B6 from supplements alone in adults reporting use of supplements 
containing vitamin B6 is 2.0 mg/day (median 1.2 mg/day), P5 intake is 0.4 mg/day and P95 
intake is 5.3 mg/day.  
13-year-olds (n=687) 
The mean intake of vitamin B6 from the diet alone is 1.2 mg/day (median 1.1 mg/day) in 13-
year-olds. The P5 intake is 0.5 mg/day and the P95 intake is 2.1 mg/day. 
In Ungkost 3 (13-year-olds), 158 participants (23%) reported use of supplements containing 
vitamin B6. Their mean total intake of vitamin B6 including that from food supplements is 2.1 
mg/day (median 2.0 mg/day), P5 intake is 1.1 mg/day and P95 intake is 3.1 mg/day. 
Mean intake of vitamin B6 from supplements alone in 13-year-olds reporting use of 
supplements containing vitamin B6 is 0.9 mg/day (median 0.9 mg/day), P5 intake is 0.3 
mg/day and P95 is 1.7 mg/day 
9-year-olds (n=636) 
The mean intake of vitamin B6 from the diet alone is 1.1 mg/day (median 1.0 mg/day) in 9-
year-olds. The P5 intake is 0.5 mg/day and the P95 intake is 1.7 mg/day. 
In Ungkost 3 (9-year-olds), 209 participants (33%) reported use of supplements containing 
vitamin B6. Their mean total intake of vitamin B6 including that from food supplements is 1.7 
mg/day (median 1.6 mg/day), P5 intake is 1.0 mg/day and P95 intake is 2.5 mg/day. 
Mean intake of vitamin B6 from supplements alone in 9-year-olds reporting use of 
supplements containing vitamin B6 is 0.7 mg/day (median 0.6 mg/day), P5 intake is 0.2 
mg/day and P95 is 1.2 mg/day. 
4-year-olds (n=399) 
The mean intake of vitamin B6 from the diet alone is 0.9 mg/day (median 0.9 mg/day) in 4-
year-olds. The P5 intake is 0.5 mg/day and the P95 intake is 1.4 mg/day. 
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In Ungkost 3 (4-year-olds), 168 participants (42%) reported use of supplements containing 
vitamin B6. Their mean total intake of vitamin B6 including that from food supplements is 
1.6 mg/day (median 1.6 mg/day), P5 intake is 1.0 mg/day and P95 intake is 2.3 mg/day. 
Mean intake of vitamin B6 from supplements alone in 4-year-olds reporting use of 
supplements containing vitamin B6 is 0.9 mg/day (median 0.9 mg/day), P5 intake is 
0.5 mg/day and P95 is 1.4 mg/day. 
2-year-olds (n=1674) 
The mean intake of vitamin B6 from the diet alone is 0.9 mg/day (median 0.9 mg/day) in 2-
year-olds. The P5 intake is 0.5 mg/day and the P95 intake is 1.4 mg/day. 
In Småbarnskost 2007, 554 participants (33%) reported use of supplements containing 
vitamin B6. Their mean total intake of vitamin B6 including that from food supplements is 1.5 
mg/day (median 1.4 mg/day), P5 intake is 0.8 mg/day and P95 intake is 2.3 mg/day. 
Mean intake of vitamin B6 from supplements alone in 2-year-olds reporting use of 
supplements containing vitamin B6 is 0.6 mg/day (median 0.6 mg/day). P95 intake of B6 
from supplements is 1.2 mg/day.  
3.3 Scenario calculations for vitamin B6 
For scenario calculations VKM used the intake groups below P5 and above P95 from food 
alone to calculate vitamin B6 intake and added the suggested supplementation levels from 
NFSA (2, 6, 8, 10, 20 or 25 mg B6 per day), see Tables 3.3-1 and 3.3-2.  
Table 3.3-1 Calculated total B6 intakes for various age groups in scenarios with 2, 6, 8, 10, 20 or 
25 mg as supplements added to the P5 of intake from food alone (mg/day).  
Age 
group 
P5 
from 
food 
Including  
2 mg from 
suppl 
Including  
6 mg from 
suppl 
Including  
8 mg from 
suppl 
Including 10 
mg from 
suppl 
Including 20 
mg from 
suppl 
Including 25 
mg from 
suppl 
Adults 0.8 2.8 6.8 8.8 10.8 20.8 25.8 
13 years 0.5 2.5 6.5 8.5 10.5 20.5 25.5 
9 years  0.5 2.5 6.5 8.5 10.5 20.5 25.5 
4 years  0.5 2.5 6.5 8.5 10.5 20.5 25.5 
2 years  0.5 2.5 6.5 8.5 10.5 20.5 25.5 
 
Table 3.3-2 Calculated total B6 intakes for various age groups in scenarios with 2, 6, 8, 10, 20 or 
25 mg as supplements added to the P95 of intake from food alone (mg/day).  
Age 
group 
P95 
from 
food 
Including  
2 mg from 
suppl 
Including  
6 mg from 
suppl 
Including  
8 mg from 
suppl 
Including 
10 mg from 
suppl 
Including 
20 mg from 
suppl 
Including 
25 mg from 
suppl 
Adults 3.0 5.0 9.0 11 13 23 29 
13 years 2.1 4.1 8.1 10.1 12.1 22.1 27.1 
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Age 
group 
P95 
from 
food 
Including  
2 mg from 
suppl 
Including  
6 mg from 
suppl 
Including  
8 mg from 
suppl 
Including 
10 mg from 
suppl 
Including 
20 mg from 
suppl 
Including 
25 mg from 
suppl 
9 years  1.7 3.7 7.7 9.7 11.7 21.7 26.7 
4 years  1.4 3.4 7.4 9.4 11.4 21.4 26.4 
2 years  1.4 3.4 7.4 9.4 11.4 21.4 26.4 
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4 Assessment of the intakes of 
vitamin B6 
4.1 Evaluation of intakes of vitamin B6, including scenarios with 
supplementation 
Dietary calculations have been performed for intake in P5, P25, mean, P50, P75 and P95 in 
children (2-, 4- and 9-year-olds), adolescents (13-year-olds) and in adult men and women. 
The dietary calculations have been performed among vitamin B6 supplement users as well as 
without use of supplements. 
Mean and median intakes of vitamin B6 from diet are within the recommended intakes for all 
age and sex groups, except for 9- and 13-year-old girls where mean and median intakes 
were below RI. Only the 2-year-old children reach the recommended intake in P5 and 4-
year-old children in P25. For 9- and 13-year-old girls recommended intake is reached in P75 
from diet alone. 
 
Figure 4.1-1: Recommended intake, mean intake, intake at P95 and suggested UL for vitamin B6 in 
mg/day.  
To illustrate the consequences of vitamin B6 supplementation at high dietary intakes, the 
example doses 2, 6, 8, 10, 20 and 25 mg/day were added to the 95-percentile of vitamin B6 
intake from diet alone for each age group. As illustrated in the scenarios (Table 3.3-2), 2- 
and 4-year-old children with a dietary intake from food at P95 will exceed UL if 
0
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supplemented with a dose of 6 mg vitamin B6 per day or higher. Nine-year-old children with 
a dietary intake from food at P95 will exceed UL if supplemented with 10 mg vitamin B6 per 
day or higher, and 13-year-old adolescents with a dietary intake from food at P95 will exceed 
UL if supplemented with 20 mg vitamin B6 per day or higher. Adults with a dietary intake 
from food at P95 will exceed UL if supplemented with 25 mg vitamin B6 per day.  
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5 Uncertainties 
It should be noted that the intakes have been calculated based on various dietary surveys 
for the different age categories and a comparison of calculations across age groups can be 
misleading. The calculated intakes in the higher and lower percentiles are always associated 
with a higher degree of uncertainty than mean or median intakes.  
The percentile estimates of dietary intake are prone to random error due to the limited 
number of participants in the dietary surveys. The largest degree of uncertainty is present in 
the estimated percentiles for 4-year-olds with a sample size of n=399, corresponding to 
about 20 observations below the 5-percentile and above the 95-percentile, respectively. 
Another issue is the validity of the estimated exposure data. Low participation rates in the 
national dietary surveys give rise to systematic errors and limit the representativeness of the 
participants compared with the background population in Norway. The participation rates 
among adults, 13-, 9-, 4- and 2-year-olds in the dietary surveys were 37%, 53%, 55%, 
20%, and 56%, respectively. In general, those participating had a considerably higher 
education level than the background population, and they are expected to represent a 
health-conscious subgroup of the population. Some population subgroups are not covered, 
e.g. ethnic minorities. 
For the determinations of the ULs for vitamin B6, EFSA, IOM and EVM have not reached the 
same conclusions, indicating uncertainty regarding establishment of these ULs both for 
adults, and even more for children and adolescents. Long-term RCTs are requested by all 
these scientific bodies to ascertain ULs. 
  
  
VKM Report 2017: 3  31 
6 Answers to the terms of reference 
The Norwegian Food Safety Authority (NFSA, Mattilsynet) has requested the Norwegian 
Scientific Committee for Food Safety (VKM) to assess the intake of vitamin B6 from the diet, 
including fortified products, in all age groups in the population above 1 year in relation to 
tolerable upper intake levels (ULs).  
VKM was also requested to conduct scenario estimations to illustrate the consequences of 
amending the existing maximum limit for vitamin B6 (to 2, 6, 8, 10, 20 or 25 mg/day, as 
examples) in food supplements. The existing maximum limit for vitamin B6 in food 
supplements is 4.2 mg/day. 
Dietary intake calculations of vitamin B6 have been performed for intake in the P5, P25, 
mean, P50, P75 and P95 in 2-, 4- and 9-year-old children, 13-year-old adolescents and 
among adult men and women. The dietary calculations have been performed among vitamin 
B6 supplement users as well as without use of supplements.  
To illustrate the consequences of supplementation with 2, 6, 8, 10, 20 or 25 mg/day in the 
different age groups, VKM has used the scenarios with P95 from food and added the 
suggested amounts of supplements. VKM has compared these scenarios with SCF's UL for 
adults and body weight adjusted ULs for children for exceedance. In these scenarios, the 2-, 
and 4-year-old children will exceed UL with use of 6 mg/day of vitamin B6 in supplements. 
The 9-year-old children will exceed UL with supplemental use of 10 mg/day. The 13-year-old 
adolescents will exceed UL with 20 mg/day of vitamin B6 in supplements. Adults will exceed 
UL with use of 25 mg/day of vitamin B6 in supplements. 
An overview of the conclusions is presented in Table 6-1. 
Table 6-1 An overview of the conclusions for vitamin B6.  
Green: No exceedance of the UL. 
Red: Exceedance of the UL. 
Doses in 
supplements 
Age group 
2 
mg/day 
6 
mg/day 
8 
mg/day 
10 
mg/day 
20 
mg/day 
25 
mg/day 
Adults       
13 years       
9 years        
4 years       
2 years        
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7 Data gaps 
Long-term RCTs with vitamin B6 that also thoroughly address adverse health effects are 
missing. 
More age groups should be included in dietary surveys in addition to subgroups like different 
ethnical groups.  
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Appendix I 
Summary tables of the intake of vitamin B6 for all age groups 
Intakes of vitamin B6 in the various age groups are presented in the tables below. The tables 
summarise intakes from the diet alone, B6 containing supplements alone (users only) and 
total intakes from both diet and supplements (Tables 1-6). Intakes are also given for both 
genders. 
Table 1 Vitamin B6 intakes from diet alone in various age groups (mg/day). 
 Adults 
(n=1787) 
13 years 
(n=687) 
9 years 
(n= 636) 
4 years 
(n=399) 
2 years 
(n=1674) 
B6 from diet alone, mean 1.7 1.2 1.0 0.9 0.9 
B6 from diet alone, median 1.6 1.1 1.0 0.9 0.9 
B6 from diet alone, P5 0.8 0.5 0.5 0.5 0.5 
B6 from diet alone, P25 1.2 0.8 0.8 0.8 0.7 
B6 from diet alone, P75 2.1 1.4 1.2 1.1 1.0 
B6 from diet alone, P95 3.0 2.1 1.7 1.4 1.4 
Table 2 Vitamin B6 supplement users intake of total B6 from diet and supplements, and from 
supplements alone (users only), in various age groups (mg/day). 
 Adults  
(n=416) 
13 years  
(n=158) 
9 years  
(n=209) 
4 years 
(n=168) 
2 years  
(n=554) 
Total B6 from diet and supplements, mean 3.6 2.1 1.7 1.6 1.5 
Total B6 from diet and supplements, median 2.9 2.0 1.6 1.6 1.4 
Total B6 from diet and supplements, P5 1.7 1.1 1.0 1.0 0.8 
Total B6 from diet and supplements, P25 2.3 1.7 1.4 1.3 1.1 
Total B6 from diet and supplements, P75 3.8 2.5 2.0 1.9 1.7 
Total B6 from diet and supplements, P95 7.4 3.1 2.5 2.3 2.3 
B6 from supplements alone, mean 2.0 0.9 0.7 0.9 0.9 
B6 from supplements alone, median 1.2 0.9 0.6 0.9 0.9 
B6 from supplements alone, P5 0.4 0.3 0.2 0.5 0.5 
B6 from supplements alone, P25 1.0 0.4 0.5 0.7 0.7 
B6 from supplements alone, P75 2.0 1.2 0.8 1.1 1.0 
B6 from supplements alone, P95 5.3 1.7 1.2 1.4 1.4 
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Table 3 Vitamin B6 intakes from diet alone in various age groups, women/girls (mg/day). 
 Women 
 
(n=925) 
Girls  
13 years 
(n= 355) 
Girls  
9 years 
(n= 341) 
B6 from diet alone, mean 1.5 1.1 1.0 
B6 from diet alone, median 1.4 1.0 0.9 
B6 from diet alone, P5 0.7 0.5 0.5 
B6 from diet alone, P25 1.1 0.7 0.8 
B6 from diet alone, P75 1.8 1.3 1.2 
B6 from diet alone, P95 2.5 1.9 1.6 
Table 4 Vitamin B6 supplement users intake of total B6 from diet and supplements, and from 
supplements alone, in various age groups, women/girls (mg/day). 
 Women 
(n=262) 
Girls 13 years 
 (n= 82) 
Girls 9 years 
(n=125) 
Total B6 from diet and supplements, mean 3.6 1.9 1.6 
Total B6 from diet and supplements, median 2.8 1.9 1.6 
Total B6 from diet and supplements, P5 1.6 0.9 0.8 
Total B6 from diet and supplements, P25 2.1 1.6 1.3 
Total B6 from diet and supplements, P75 3.7 2.2 2.0 
Total B6 from diet and supplements, P95 7.3 3.1 2.6 
B6 from supplements alone, mean 2.1 0.8 0.7 
B6 from supplements alone, median 1.2 0.8 0.6 
B6 from supplements alone, P5 0.40 0.3 0.2 
B6 from supplements alone, P25 1.0 0.4 0.5 
B6 from supplements alone, P75 2.0 1.1 0.9 
B6 from supplements alone, P95 5.7 2.0 1.2 
Table 5 Vitamin B6 intakes from diet alone in various age groups, men/boys (mg/day). 
 Men 
 
(n=862) 
Boys  
13 years 
(n= 332) 
Boys  
9 years 
(n= 295) 
B6 from diet alone, mean 1.9 1.3 1.1 
B6 from diet alone, median 1.8 1.2 1.0 
B6 from diet alone, P5 0.92 0.6 0.6 
B6 from diet alone, P25 1.4 0.9 0.8 
B6 from diet alone, P75 2.3 1.5 1.3 
B6 from diet alone, P95 3.3 2.2 1.8 
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Table 6 Vitamin B6 supplement users intake of total B6 from diet and supplements, and from 
supplements alone, in various age groups, men/boys (mg/day). 
 Men 
(n=154) 
Boys 13 years 
(n= 76) 
Boys 9 years 
(n=84) 
Total B6 from diet and supplements, mean 3.7 2.2 1.7 
Total B6 from diet and supplements, median 3.1 2.2 1.7 
Total B6 from diet and supplements, P5 1.9 1.2 1.1 
Total B6 from diet and supplements, P25 2.4 1.8 1.5 
Total B6 from diet and supplements, P75 4.2 2.6 2.0 
Total B6 from diet and supplements, P95 7.4 3.1 2.4 
B6 from supplements alone, mean 1.8 0.9 0.7 
B6 from supplements alone, median 1.2 0.9 0.7 
B6 from supplements alone, P5 0.50 0.3 0.2 
B6 from supplements alone, P25 1.0 0.6 0.5 
B6 from supplements alone, P75 2.0 1.4 0.7 
B6 from supplements alone, P95 5.1 1.4 1.2 
 
 
